Detalles de la búsqueda
1.
Evaluation of a cell-based osteogenic formulation compliant with good manufacturing practice for use in tissue engineering.
Mol Biol Rep
; 47(7): 5145-5154, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562174
2.
Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow-derived multipotent mesenchymal stromal cell expansion cultures.
Cytotherapy
; 21(1): 32-40, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30447901
3.
Assessment of biodistribution using mesenchymal stromal cells: Algorithm for study design and challenges in detection methodologies.
Cytotherapy
; 19(9): 1060-1069, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28734679
4.
Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells.
Cytotherapy
; 18(9): 1197-208, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27424149
5.
Treatment of non-hypertrophic pseudoarthrosis of long bones with a Tissue Engineered Product loaded with autologous bone marrow-derived Mesenchymal Stromal Cells: Results from a phase IIa, prospective, randomized, parallel, pilot clinical trial comparing to iliac crest autograft.
Injury
; 55(7): 111596, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797000
6.
Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.
Lancet Oncol
; 12(13): 1214-21, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21982422
7.
Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton's Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance.
Cells
; 11(14)2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35883596
8.
Streamlining the qualification of computerized systems in GxP-compliant academic cell therapy facilities.
Cytotherapy
; 18(9): 1237-9, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27421738
9.
SARS-CoV-2/COVID-19 pandemic: first wave, impact, response and lessons learnt in a fully integrated Regional Blood and Tissue Bank. A narrative report.
Blood Transfus
; 19(2): 158-167, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539280
10.
Randomized clinical trial: expanded autologous bone marrow mesenchymal cells combined with allogeneic bone tissue, compared with autologous iliac crest graft in lumbar fusion surgery.
Spine J
; 20(12): 1899-1910, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32730985
11.
First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft.
EBioMedicine
; 54: 102729, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32304998
12.
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's Jelly.
Cells
; 8(5)2019 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31117301
13.
Clinical translation of a mesenchymal stromal cell-based therapy developed in a large animal model and two case studies of the treatment of atrophic pseudoarthrosis.
J Tissue Eng Regen Med
; 12(1): e532-e540, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27684058
14.
Final results of a phase I-II trial using ex vivo expanded autologous Mesenchymal Stromal Cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration.
Knee
; 23(4): 647-54, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26783191
15.
Qualification of computerized monitoring systems in a cell therapy facility compliant with the good manufacturing practices.
Regen Med
; 11(6): 521-8, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27513321
Resultados
1 -
15
de 15
1
Próxima >
>>